Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
In the latest session, Prothena Corporation plc (NASDAQ: PRTA) closed at $13.75 down -5.79% from its previous closing price of $14.60. In other words, the price has decreased by -$5.79 from its previous closing price. On the day, 0.63 million shares were traded.
Ratios:
For a deeper understanding of Prothena Corporation plc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 10.01 and its Current Ratio is at 10.01. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.02.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Chardan Capital Markets on December 20, 2024, initiated with a Buy rating and assigned the stock a target price of $40.
On January 30, 2024, BofA Securities Downgraded its rating to Neutral which previously was Buy and also lowered its target price recommendation from $68 to $38.
On December 12, 2023, Deutsche Bank started tracking the stock assigning a Buy rating and target price of $62.Deutsche Bank initiated its Buy rating on December 12, 2023, with a $62 target price.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 5.48 while its Price-to-Book (P/B) ratio in mrq is 1.52.
Stock Price History:
Over the past 52 weeks, PRTA has reached a high of $30.85, while it has fallen to a 52-week low of $11.70. The 50-Day Moving Average of the stock is -4.93%, while the 200-Day Moving Average is calculated to be -23.41%.
Shares Statistics:
A total of 53.83M shares are outstanding, with a floating share count of 42.50M. Insiders hold about 21.05% of the company’s shares, while institutions hold 98.08% stake in the company.
